TRUP vs. OSCR, ALHC, CLOV, NEUE, BHG, MOH, UNH, ELV, CI, and HUM
Should you be buying Trupanion stock or one of its competitors? The main competitors of Trupanion include Oscar Health (OSCR), Alignment Healthcare (ALHC), Clover Health Investments (CLOV), NeueHealth (NEUE), Bright Health Group (BHG), Molina Healthcare (MOH), UnitedHealth Group (UNH), Elevance Health (ELV), The Cigna Group (CI), and Humana (HUM). These companies are all part of the "hospital & medical service plans" industry.
Trupanion (NASDAQ:TRUP) and Oscar Health (NYSE:OSCR) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations.
Oscar Health has a net margin of -0.82% compared to Trupanion's net margin of -2.31%. Oscar Health's return on equity of -5.77% beat Trupanion's return on equity.
Trupanion received 492 more outperform votes than Oscar Health when rated by MarketBeat users. Likewise, 66.41% of users gave Trupanion an outperform vote while only 55.17% of users gave Oscar Health an outperform vote.
Trupanion has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Trupanion, indicating that it is currently the more affordable of the two stocks.
In the previous week, Oscar Health had 9 more articles in the media than Trupanion. MarketBeat recorded 16 mentions for Oscar Health and 7 mentions for Trupanion. Trupanion's average media sentiment score of 0.93 beat Oscar Health's score of 0.78 indicating that Trupanion is being referred to more favorably in the media.
75.7% of Oscar Health shares are held by institutional investors. 5.5% of Trupanion shares are held by insiders. Comparatively, 25.1% of Oscar Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Trupanion has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, Oscar Health has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500.
Trupanion presently has a consensus target price of $32.80, suggesting a potential upside of 9.81%. Oscar Health has a consensus target price of $18.57, suggesting a potential downside of 6.96%. Given Trupanion's higher probable upside, equities research analysts plainly believe Trupanion is more favorable than Oscar Health.
Summary
Oscar Health beats Trupanion on 11 of the 19 factors compared between the two stocks.
Get Trupanion News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRUP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TRUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trupanion Competitors List
Related Companies and Tools
